Lifetime Risk of Cardiovascular Disease Among Individuals With and Without Diabetes Stratified by Obesity Status in the Framingham Heart Study
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—We assessed the lifetime risk of cardiovascular disease (CVD) among individuals with and without obesity and diabetes. RESEARCH DESIGN AND METHODS—Participants were drawn from the original and offspring cohorts of the Framingham Heart Study. Lifetime (30-year) risk of CVD was assessed using a modified Kaplan-Meier approach adjusting for the competing risk of death, beginning from age 50 years. RESULTS—Over 30 years, the lifetime risk of CVD among women with diabetes was 54.8% among normal-weight women and 78.8% among obese women. Among normal-weight men with diabetes, the lifetime risk of CVD was 78.6%, whereas it was 86.9% among obese men. CONCLUSIONS—The lifetime risk of CVD among individuals with diabetes is high, and this relationship is further accentuated with increasing adiposity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Individuals with type 2 diabetes have a lifetime risk of CAD that includes 67% of women and 78% of men and is exacerbated by obesity ( 22 , 80 , 165 ).”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [80]
Experimental — accuracy not yet measuredIn the citing paper
“In the Framingham Heart Study, Fox [7] reported that, along with the increasing T2DM prevalence, the attributable risk of CVD due to T2DM increased from 5.4% in the period 1952–1974 to 8.7% in the period 1975 and 1998.”
From Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (2018) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lifetime risk for diabetes mellitus in the United States
Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515
Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age
Lloyd-Jones, D. M., Leip, E. P., Larson, M. G., D’Agostino, R. B., Beiser, A., Wilson, P. W. F., Wolf, P. A., & Levy, D. (2006) · Circulation · doi:10.1161/circulationaha.105.548206 · Cited by 1,298 · cited 1×
“The lifetime risk of coronary heart disease is 42% among men and 25% among women (2) and is higher among individuals with diabetes (3).”
Self-citationLifetime risk of developing coronary heart disease
Lloyd-Jones, D. M., Larson, M. G., Beiser, A., & Levy, D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10279-9 · Cited by 929
Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study
Fox, C. S., Coady, S., Sorlie, P. D., D’Agostino, R. B., Pencina, M. J., Vasan, R. S., Meigs, J. B., Levy, D., & Savage, P. J. (2007) · Circulation · doi:10.1161/circulationaha.106.658948 · Cited by 656
Self-citationImpact of Recent Increase in Incidence on Future Diabetes Burden
Narayan, K. M. V., Boyle, J. P., Geiss, L. S., Saaddine, J. B., & Thompson, T. J. (2006) · Diabetes Care · doi:10.2337/dc06-1136 · Cited by 602
Effect of BMI on Lifetime Risk for Diabetes in the U.S.
Narayan, K. M. V., Boyle, J. P., Thompson, T. J., Gregg, E. W., & Williamson, D. F. (2007) · Diabetes Care · doi:10.2337/dc06-2544 · Cited by 510
Gaynor, J. J., Feuer, E. J., Tan, C. C., Wu, D. H., Little, C. R., Straus, D. J., Clarkson, B. D., & Brennan, M. F. (1993) · Journal of the American Statistical Association · doi:10.1080/01621459.1993.10476289 · Cited by 483 · cited 2×
“For computing the 10, 20, and 30-year risks, we used the Practical Incidence Estimators (PIE) macro approach developed by Beiser et al (4) based on a method proposed by Gaynor et al (5) as previously described (6).”
Beiser, A., D'Agostino, R. B., Seshadri, S., Sullivan, L. M., & Wolf, P. A. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000615/30)19:11/12<1495::aid-sim441>3.0.co;2-e · Cited by 186
Self-citationEstimated Risks for Developing Obesity in the Framingham Heart Study
Vasan, R. S., Pencina, M. J., Cobain, M., Freiberg, M. S., & D'Agostino, R. B. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-7-200510040-00005 · Cited by 158
Self-citationTemporal Trends in BMI Among Adults With Diabetes
Leibson, C. L., Williamson, D. F., Melton, L. J., Palumbo, P. J., Smith, S. A., Ransom, J. E., Schilling, P. L., & Narayan, K. M. V. (2001) · Diabetes Care · doi:10.2337/diacare.24.9.1584 · Cited by 112 · cited 1×
“The prevalence of obesity among individuals with diabetes continues to rise (1).”
Cited by
Items 201–246 of 246
Obesity and the Risk for Type 2 Diabetes
Gougeon, R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391884-0.00031-7 · Cited by 1
Exercise in Patients with Advanced Diabetic Complications
Lee, S. H., Ahn, J., & Kim, J. (2011) · Journal of Korean Diabetes · doi:10.4093/jkd.2011.12.1.33
Cardiovascular disease is prevented over the long term by better blood glucose control
Meigs, J. B., & Masoudi, F. A. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-009-0006-y
“People developing type 2 diabetes have a high lifetime risk of CVD and CVD death, especially if they are obese [ 6 ].”
BackgroundWaist circumference with overweight and high blood pressure in adults
Fajardo, C. M., Martínez, R., Rodríguez, E. F.-B., Díaz, S. G., & Albert, M. J. (2012) · Revista Habanera de Ciencias Médicas
Rees, A. (2014) · The British Journal of Diabetes · doi:10.15277/bjdvd.2014.003
Medikamentöse Diabetestherapie bei adipösen Patienten
Schumm‐Draeger, P., & Siegmund, T. (2013) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/s-0037-1618809
“Darüber hinaus belegen epidemiologische Daten die Hypothese, dass gerade die Glukosestoffwechselstörung die Auswirkungen zusätzlicher Risikofaktoren wie Bluthochdruck oder Dyslipidämie erhöht (7).”
BackgroundThe Problem of Diabetes and Cardiovascular Disease: Include Women in the Solution
Witt, D., Boucher, J. L., & Hayes, S. N. (2013) · Diabetes Spectrum · doi:10.2337/diaspect.26.3.139 · Cited by 1
Kardiovaskuläre Hochrisikopatienten mit Diabetes mellitus
Siegmund, T. (2013) · CardioVasc · doi:10.1007/s15027-013-0105-z
“Epidemiologische Daten belegen die Hypothese, dass der Diabetes die Auswirkungen zusätzlicher Risikofaktoren wie Bluthochdruck oder Dyslipidämie erhöht [3, 4, 5].”
BackgroundGlucose lowering therapy of type 2 diabetes – the art of possible
Зуєв, К. О., & Когут, Д. Г. (2016) · Clinical endocrinology and endocrine surgery · doi:10.24026/1818-1384.4(56).2016.87232
Alsaad, A. A., & Shapiro, B. P. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2017-110832
Cho, Y., & Kang, E. S. (2018) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2018.7.1.21
How can older adults combat diabetes to achieve a longer and healthier life
Shang, Y. (2021) · Figshare · Cited by 6
Study of determinants of cardiovascular morbidity among diabetes patients
Kundu, S. S., Majumdar, K. K., Mukherjee, D., Sikder, R., Dey, R., & Joardar, G. K. (2021) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20210807
“Obesity is an established risk factor for cardiovascular disease.(23,24) It was also shown that overweight and obesity are highly prevalent in T2DM patients with high CV risk and that BMI and waist circumference are related to major cardio metabolic risk factors.”
BackgroundTİP 2 DİYABETLİ HASTALARIN TEDAVİSİNDE KILAVUZLARA NE KADAR UYGUN HAREKET EDİYORUZ?
Toprak, İ. D., Alibakan, Ö. K., Köstek, B., Acar, M., Aslan, İ. B., Yılmaz, U., Eruzun, H., Arman, Y., & Tükek, T. (2020) · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi · doi:10.26650/iuitfd.2021.828573 · Cited by 1
Cardiovascular Health in Professional Rugby Union Athletes
McHugh, C. (2021) · Arrow@dit (Dublin Institute of Technology)
Guidoni, C. M., & Pereira, L. R. L. (2012) · DOAJ (DOAJ: Directory of Open Access Journals)
Current literature in diabetes
(2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.918
Prediction of 10-Year Risk of Cardiovascular Disease among Diabetic Patients in Bangladesh
Akter, N. (2022) · Delta Medical College Journal · doi:10.3329/dmcj.v8i1.58961 · Cited by 1
Walleghen, E. L. V., Steeves, B. A., & Raynor, H. A. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780195342819.013.0029 · Cited by 2
O PAPEL DA FISIOTERAPIA CARDIOVASCULAR NA ATENÇÃO PRIMÁRIA À SAÚDE
de Souza, C. G., de Almeida, I. L. G. I., Silva, K. L. S., Vitorino, D. F. D. M., & Costa, H. S. (2022) · Editora Omnis Scietia eBooks · doi:10.47094/978-65-5854-764-8/178-194
Sarker, A., Ramesh, A. S., Tello, C. M., Jamil, D., Tran, H. H.-V., Mansoor, M., Butt, S. R., Satnarine, T., Ratna, P., & Hamid, P. (2022) · Cureus · doi:10.7759/cureus.29069
“Type 2 diabetes mellitus (T2DM) and cardiovascular disease are the leading causes of increased hospitalization, morbidity, and mortality worldwide [1-3].”
BackgroundRecent Advancements of Supramolecules in the Evolution of Cardiovascular Drugs
Kiremit, M., & Tekinay, A. B. (2022) · Springer eBooks · doi:10.1007/978-3-031-21900-9_8
do Prado, F. V., Muniz, F. W. M. G., Fernandez, M. D. S., Sachetti, D. G., Rõsing, C. K., & Colussi, P. R. G. (2022) · Saúde e Desenvolvimento Humano · doi:10.18316/sdh.v10i3.8833 · Cited by 1
Efecto de la ingesta de polifenoles en biomarcadores y riesgo cardiovascular
García, M. R. (2022) · Buleria (Universidad de León) · doi:10.18002/10612/15968
Differences of Diabetes Treatment and Care in Various Ethnic Minorities
Yuan, Y. E., & Caballero, A. E. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_35
Combatting the Fructose Epidemic: Fruitful or Fruitless?
Buziau, A. M. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231113ab
Rai, S., Sherpa, M. L., Khandelwal, B., Bhandari, S., & Bhutia, R. D. (2024) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v15i1.59241
Ramírez, S. M., & García, D. T. (2021) · RD-ICUAP · doi:10.32399/icuap.rdic.2448-5829.2021.19.504
Relationship Between Dyslipidemia and Alzheimer’s Disease
Bolayırlı, M., & Kücür, M. (2024) · doi:10.69860/nobel.9786053359166.12
Harnessing Marine-Derived Compounds for Cardiovascular Health: Sea to Heart
Singh, A., & Kaur, P. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-5878-8.ch010
Jowi, S. O., Otieno, F. C. F., & Ogola, E. N. (2024) · British journal of healthcare and medical research · doi:10.14738/bjhmr.115.17745
Wang, W., Qiao, J., Man, F., Luo, J., Zhang, J., Zhang, L., Zhang, J., Shi, W., Jia, P., Pan, Q., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112245
Keshavarz, F., Nasli‐Esfahani, E., Zeinalabedini, M., & Azadbakht, L. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01688-4
“CVD stands out as a primary contributor to disability and mortality in the world [ 4], and its incidence is significantly higher in individuals with type 2 diabetes [ 5].”
Environmental Noise and Outdoor Light Pollution in the Pathogenesis of Cardiovascular Toxicity
Ahmed, Z. A., Chaudhary, F., & Agrawal, D. K. (2025) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-90598-8_29
Rodopaios, N. E., Apostolopoulou, A., Koulouri, A.-A., Papadopoulou, S. Κ., Skepastianos, P., Hassapidou, M. N., Tsimtsiou, Z., & Kafatos, A. G. (2025) · Nutrients · doi:10.3390/nu17203308
“Therefore, investigating the possible effects of practices associated with COC fasting in individuals with increased BMI could provide valuable insights into dietary recommendations for weight management and disease prevention in high-risk populations [25,26].”
Zhang, R., Mamza, J., Morris, T., Godfrey, G., Asselbergs, F. W., Denaxas, S., Hemingway, H., & Banerjee, A. (2022) · Figshare · doi:10.6084/m9.figshare.19135870
HOW DO WE FOLLOW THE GUIDELINES IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES?
Toprak, İ. D., Alibakan, Ö. K., Acar, M. A., Köstek, B., Aslan, İ. B., Yılmaz, U., Eruzun, H., Arman, Y., & Tükek, T. (2020) · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi
Navas, A., NOONE, J., Laney, N., SHETH, S. T., Tan, X., Liang, Y. M., Munoz, P., & Swift, C. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01875-3 · Cited by 1
“Estimates of lifetime risk of CV disease for people with T2D range from 55% to 79% [2, 3], with an even greater risk of disease among people with comorbid obesity [2].”
Hellberg, A., Sundqvist, M. L., Hirschberg, A. L., Catrina, S., Eriksson, I., Ekberg, N. R., & Brismar, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146460
“T2D is independently intertwined with CVD [4,5].”
Šrámek, J., Pierzynová, A., Melenovský, V., & Kučera, T. (2026) · PLoS ONE · doi:10.1371/journal.pone.0354451
Tan, X., Liang, Y. M., 陈, 忠., Xie, L., Guevarra, M., Swift, C., & de Havenon, A. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01919-8
“As many as two-thirds of Americans with type 2 diabetes (T2D) may develop atherosclerotic cardiovascular disease (ASCVD) [2, 3].”
Cardiovascular disease among diabetic women with bilateral oophorectomy.
Appiah, D. (2013) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/43
Metadata
- Authors
- Fox, C. S., Pencina, M. J., Wilson, P. W. F., Paynter, N. P., Vasan, R. S., & D’Agostino, R. B.
- Affiliations
- Brigham and Women's Hospital (US)
- Boston University (US)
- Emory University (US)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2008-08-01
- Volume
- 31
- Issue
- 8
- Pages
- 1582-1584
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2494632
- OpenAlex
- W2154705833
- Cited by
- 247
- References
- 10
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 17 · 2023: 13 · 2022: 22 · 2021: 17 · 2020: 10 · 2019: 10 · 2018: 9 · 2017: 14 · 2016: 10 · 2015: 11 · 2014: 13 · 2013: 17 · 2012: 18
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- OpenBU (Boston University) (submittedVersion, cc-by-nc-nd)
- Funders
- National Institutes of Health (n01hc25195-41-0-1)
- National Heart, Lung, and Blood Institute (N01‐HC25195, K24HL004334, N01-HC-025195)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- diabetes mellitus, obesity, adiposity, sex differences, competing risk of death, Framingham Heart Study, women
- MeSH terms
- Aged, Aged, 80 and over, Cardiovascular Diseases, Female, Humans, Male, Middle Aged, Obesity, Time Factors, Risk Assessment, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.